ELFABRIO 5 mg/2.5mL (Pegunigalsidase Alfa INJECTION, SOLUTION, CONCENTRATE) 5 mg/2.5mL

Elfabrio 5 mg/2.5mL is an intravenous solution containing pegunigalsidase alfa, used for enzyme replacement therapy. This single-dose injection is manufactured by Chiesi USA, Inc. and is designed for specific medical conditions.

Strength

5 mg/2.5mL

Pack Size

1 VIAL, SINGLE-DOSE in 1 CARTON (10122-165-02) / 2.5 mL in 1 VIAL, SINGLE-DOSE

Manufacturer / TM Owner

Chiesi USA, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Elfabrio is primarily used for enzyme replacement therapy. It is administered intravenously to address certain medical conditions that require enzyme supplementation. The active ingredient, pegunigalsidase alfa, helps in managing these conditions by providing the necessary enzymes that the body may lack.

Side Effects

Common effects of Elfabrio may include reactions at the injection site, such as redness or swelling. Some individuals might experience general discomfort or mild allergic reactions. It is important to monitor for any adverse effects and consult a healthcare provider if concerns arise.

Precautions & Warnings

Elfabrio should be handled with care, ensuring proper storage and administration procedures. It is crucial to follow the guidelines provided by healthcare professionals to minimize risks. Always check the packaging for any specific instructions and ensure the solution is clear before use.

Avoid Interactions

Elfabrio may interact with other medications or substances, including certain enzymes or proteins. It is advisable to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and other substances that affect the immune system should be used with caution.

Frequently Asked Questions

Elfabrio is used for enzyme replacement therapy, specifically to address conditions that require supplementation of certain enzymes.

Elfabrio is administered intravenously as a single-dose injection. It should be given by a healthcare professional following proper procedures.

Common effects may include reactions at the injection site, such as redness or swelling, and general discomfort.

Elfabrio may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Elfabrio should be stored according to the instructions provided by the manufacturer to ensure its effectiveness and safety.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.